Showing results (1251-1260 of 5,724) with videos related to

Sort By:
Pageof 573
Medical Oncology (Northwood, London, England)|October 24, 2023
VEGF/Nrp1/HIF-1α promotes proliferation of hepatocellular carcinoma through a positive feedback loopYun-Bing Wang, Kai-Wen Zheng, Yi-Yu Hu, et al.
Medical Oncology (Northwood, London, England)|March 28, 2024
Investigating the correlation between prominent viruses and hematological malignancies: a literature reviewArian Haghtalab, Milad Hejazi, Naeem Goharnia, et al.
Medical Oncology (Northwood, London, England)|March 25, 2024
Bioinformatics-based screening and analysis of the key genes involved in the influence of antiangiogenesis on myeloid-derived suppressor cells and their effects on the immune microenvironmentXiangFei Zhao, RuGang Zhao, JuYi Wen, et al.
Medical Oncology (Northwood, London, England)|March 25, 2024
Estrogen-receptor status determines differential regulation of α1- and α2-adrenoceptor-mediated cell survival, angiogenesis, and intracellular signaling responses in breast cancer cell linesHannah P Priyanka, Uday P Pratap, Rahul S Nair, et al.
Medical Oncology (Northwood, London, England)|September 1, 2023
The apoptotic effect of the Lycopodium clavatum extracts on MCF-7 human breast cancer cellsYusuf Kucukbagriacik, Mohammadreza Dastouri, Humeyra Yilmaz, et al.
Medical Oncology (Northwood, London, England)|September 1, 2023
RIG-I promotes cell proliferation in esophageal squamous cell carcinoma by facilitating p21 degradationMeng Wang, Yangyang Zhang, Liping Gao, et al.
Medical Oncology (Northwood, London, England)|August 28, 2023
Novel insights on perils and promises of miRNA in understanding colon cancer metastasis and progressionLubna Tariq, Azher Arafah, Nouroz Sehar, et al.
Medical Oncology (Northwood, London, England)|August 27, 2023
EZH2 inhibitor Tazemetostat synergizes with JQ-1 in esophageal cancer by inhibiting c-Myc signaling pathwayNan Ding, Abin You, Senxia Zhao, et al.
Medical Oncology (Northwood, London, England)|August 29, 2023
Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancerKayla V Myers Chen, Amber E de Groot, Sabrina A Mendez, et al.
Medical Oncology (Northwood, London, England)|August 23, 2023
The mechanism of LSM2 in the progression of live hepatocellular carcinoma was analyzed based on bioinformaticsPeifang Qin, Haitao Huang, Jiahui Wang, et al.
Pageof 573